Approving Children ' s Cancer Drugs Takes 6.5 Years Longer
WEDNESDAY, June 12, 2019 -- For cancer drugs ultimately approved by the U.S. Food and Drug Administration, the median lag time from first-in-human to first-in-child trials is 6.5 years, according to a study published in the May issue of the European...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Children | Food and Drug Administration (FDA) | Pharmaceuticals | Study